L1 retrotransposon expression in circulating tumor cells.

Long interspersed nuclear element 1 (LINE-1 or L1) belongs to the non-long terminal repeat (non-LTR) retrotransposon family, which has been implicated in carcinogenesis and disease progression. Circulating tumor cells (CTCs) are also known to be involved in cancer progression. The present study aime...

Full description

Bibliographic Details
Main Authors: Ioannis Papasotiriou, Katerina Pantopikou, Panagiotis Apostolou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5293242?pdf=render
id doaj-79aedfb699014a5a838e64bfe55a03b4
record_format Article
spelling doaj-79aedfb699014a5a838e64bfe55a03b42020-11-25T00:07:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017146610.1371/journal.pone.0171466L1 retrotransposon expression in circulating tumor cells.Ioannis PapasotiriouKaterina PantopikouPanagiotis ApostolouLong interspersed nuclear element 1 (LINE-1 or L1) belongs to the non-long terminal repeat (non-LTR) retrotransposon family, which has been implicated in carcinogenesis and disease progression. Circulating tumor cells (CTCs) are also known to be involved in cancer progression. The present study aimed to compare the L1 expression between circulating tumor cells and non-cancerous samples. Blood samples were collected from 10 healthy individuals and 22 patients with different types of cancer. The whole blood cells were isolated using enrichment protocols and the DNA and RNA were extracted. RT-qPCR was performed for L1-ORF1 (open reading frame 1) and L1-ORF2, using 18S rRNA as the reference gene. The data were analyzed with the Livak method and statistical analyses were carried out with the Mann-Whitney and Kruskal-Wallis tests. In parallel with the above molecular biology experiments, FISH experiments were performed on the interphase nuclei of the cells for the detection of ORF2 RNA. DNA analysis revealed the presence of both ORF1 and ORF2 in all samples. RNA expression experiments demonstrated that ORF1 was not expressed in all samples, while ORF2 was expressed at varying levels in the non-cancer samples and the samples representing the different cancer types. A significant difference in ORF2 expression was observed between the CTCs and non-cancer samples (p = 0,00043), and significant differences were also observed between normal and lung (p = 0,034), pancreatic (p = 0,022), prostate (p = 0,014), and unknown primary of origin (p = 0,0039) cancer samples. Cytogenetic analysis revealed higher levels of ORF2 in the nuclei of CTCs than in normal samples. This study highlights the significant difference in L1-ORF2 expression between CTCs and normal samples. The increased expression levels observed for CTCs may be correlated with the characteristic features of these cells.http://europepmc.org/articles/PMC5293242?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ioannis Papasotiriou
Katerina Pantopikou
Panagiotis Apostolou
spellingShingle Ioannis Papasotiriou
Katerina Pantopikou
Panagiotis Apostolou
L1 retrotransposon expression in circulating tumor cells.
PLoS ONE
author_facet Ioannis Papasotiriou
Katerina Pantopikou
Panagiotis Apostolou
author_sort Ioannis Papasotiriou
title L1 retrotransposon expression in circulating tumor cells.
title_short L1 retrotransposon expression in circulating tumor cells.
title_full L1 retrotransposon expression in circulating tumor cells.
title_fullStr L1 retrotransposon expression in circulating tumor cells.
title_full_unstemmed L1 retrotransposon expression in circulating tumor cells.
title_sort l1 retrotransposon expression in circulating tumor cells.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Long interspersed nuclear element 1 (LINE-1 or L1) belongs to the non-long terminal repeat (non-LTR) retrotransposon family, which has been implicated in carcinogenesis and disease progression. Circulating tumor cells (CTCs) are also known to be involved in cancer progression. The present study aimed to compare the L1 expression between circulating tumor cells and non-cancerous samples. Blood samples were collected from 10 healthy individuals and 22 patients with different types of cancer. The whole blood cells were isolated using enrichment protocols and the DNA and RNA were extracted. RT-qPCR was performed for L1-ORF1 (open reading frame 1) and L1-ORF2, using 18S rRNA as the reference gene. The data were analyzed with the Livak method and statistical analyses were carried out with the Mann-Whitney and Kruskal-Wallis tests. In parallel with the above molecular biology experiments, FISH experiments were performed on the interphase nuclei of the cells for the detection of ORF2 RNA. DNA analysis revealed the presence of both ORF1 and ORF2 in all samples. RNA expression experiments demonstrated that ORF1 was not expressed in all samples, while ORF2 was expressed at varying levels in the non-cancer samples and the samples representing the different cancer types. A significant difference in ORF2 expression was observed between the CTCs and non-cancer samples (p = 0,00043), and significant differences were also observed between normal and lung (p = 0,034), pancreatic (p = 0,022), prostate (p = 0,014), and unknown primary of origin (p = 0,0039) cancer samples. Cytogenetic analysis revealed higher levels of ORF2 in the nuclei of CTCs than in normal samples. This study highlights the significant difference in L1-ORF2 expression between CTCs and normal samples. The increased expression levels observed for CTCs may be correlated with the characteristic features of these cells.
url http://europepmc.org/articles/PMC5293242?pdf=render
work_keys_str_mv AT ioannispapasotiriou l1retrotransposonexpressionincirculatingtumorcells
AT katerinapantopikou l1retrotransposonexpressionincirculatingtumorcells
AT panagiotisapostolou l1retrotransposonexpressionincirculatingtumorcells
_version_ 1725417340187705344